Article thumbnail

Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury

By Xiyong Fan, Annemieke Kavelaars, Cobi J Heijnen, Floris Groenendaal and Frank van Bel

Abstract

Perinatal hypoxia-ischemia (HI) is an important cause of neonatal brain injury. Recent progress in the search for neuroprotective compounds has provided us with several promising drugs to reduce perinatal HI-induced brain injury. In the early stage (first 6 hours after birth) therapies are concentrated on prevention of the production of reactive oxygen species or free radicals (xanthine-oxidase-, nitric oxide synthase-, and prostaglandin inhibition), anti-inflammatory effects (erythropoietin, melatonin, Xenon) and anti-apoptotic interventions (nuclear factor kappa B- and c-jun N-terminal kinase inhibition); in a later stage stimulation of neurotrophic properties in the neonatal brain (erythropoietin, growth factors) can be targeted to promote neuronal and oligodendrocyte regeneration. Combination of pharmacological means of treatment with moderate hypothermia, which is accepted now as a meaningful therapy, is probably the next step in clinical treatment to fight post-asphyxial brain damage. Further studies should be directed at a more rational use of therapies by determining the optimal time and dose to inhibit the different potentially destructive molecular pathways or to enhance endogenous repair while at the same time avoiding adverse effects of the drugs used

Topics: Article
Publisher: Bentham Science Publishers Ltd
OAI identifier: oai:pubmedcentral.nih.gov:3080590
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). A decrease of cell proliferation by hypothermia in the hippocampus of the neonatal rat. Brain Res.,
  2. (2008). A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage. Stroke,
  3. (2006). Adult hippocampus derived soluble factors induce a neuronal-like phenotype in mesenchymal stem cells.
  4. (2005). Adult or perinatal brain injury: does sex matter? Stroke,
  5. (1993). Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats.
  6. (1987). Allopurinol and oxypurinol are hydroxyl radical scavengers.
  7. (2003). allopurinol and oxypurinol are not neuroprotective after oxygen/glucose deprivation in an organotypic hippocampal model, lacking functional endothelial cells. Brain Res.,
  8. (2009). Alternate pathways preserve tumor necrosis factoralpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia. Stroke,
  9. (1997). Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat
  10. (1995). Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats.
  11. (2006). Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant.,
  12. (2009). Brain injury expands the numbers of neural stem cells and progenitors in the SVZ by enhancing their responsiveness to EGF. ASN Neuro.,
  13. (2006). Brain injury in the infant: the old, the new, and the uncertain.
  14. (1999). Can magnesium sulfate reduce the risk of cerebral injury after perinatal asphyxia? Acta Pol. Pharm.,
  15. (2001). Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia.
  16. (2005). cJun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia,
  17. (2002). Clinical trials of treatments after perinatal asphyxia.
  18. (2009). Combination of deferoxamine and erythropoietin: therapy for hypoxia-ischemia-induced brain injury in the neonatal rat?
  19. (2002). Concurrent formation of peroxynitrite with the expression of inducible nitric oxide synthase in the brain during middle cerebral artery occlusion and reperfusion in rats.
  20. (2003). Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ischemia: a stereological study. Neuroscience,
  21. (2009). Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia.
  22. (2008). Current controversies in hypothermic neuroprotection.
  23. (2004). Cyclooxygenase-mediated generation of free radicals during hypoxia in the cerebral cortex of newborn piglets.
  24. (1994). Dual effects of L-NAME during transient focal cerebral ischemia in spontaneously hypertensive rats.
  25. (2008). Early high-dose erythropoietin therapy and hypothermia after outof-hospital cardiac arrest: a matched control study. Resuscitation,
  26. (2001). Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis.
  27. (2006). Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia.
  28. (2007). Effect of allopurinol supplementation on nitric oxide levels in asphyxiated newborns.
  29. (2008). Effect of melatonin on the blood oxygen transport during hypothermia and rewarming in rats.
  30. (1999). Effects of hypoxia-ischemia and inhibition of nitric oxide synthase on cerebral energy metabolism in newborn piglets.
  31. (2002). Effects of magnesium sulphate on amplitude-integrated continuous EEG in asphyxiated term neonates. Acta Paediatr.,
  32. (2007). Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation.
  33. (2001). Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture.
  34. (2009). Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain. Brain Behav. Immun.,
  35. (2007). Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke.
  36. (2009). Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics,
  37. (2004). Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxiaischemia in rats.
  38. (2007). Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke,
  39. (2005). Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia.
  40. (2001). Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells.
  41. (2009). Erythropoietin sustains cognitive function and brain volume after neonatal stroke.
  42. (2005). Expression of inducible nitric oxide synthase and cyclooxygenase-2 mRNA in brain damage induced by lipopolysaccharide and intermittent hypoxia-ischemia in neonatal rats.
  43. (2005). Expression of nitric oxide synthase isoforms and nitrotyrosine formation after hypoxia-ischemia in the neonatal rat
  44. (2008). Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy. Pediatrics,
  45. (2006). Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience,
  46. (2007). Gender-dependent pathways of hypoxia-ischemiainduced cell death and neuroprotection
  47. (2007). Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway.
  48. (2006). Glutamate-mediated excitotoxicity in neonatal hippocampal neurons is mediated by mGluR-induced release of Ca++ from intracellular stores and is prevented by estradiol.
  49. (2002). Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology,
  50. (2000). Hyperbaric oxygen down-regulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of eNOS.
  51. (2008). Hyperbaric oxygen induces endogenous neural stem cells to proliferate and differentiate in hypoxic-ischemic brain damage in neonatal rats.
  52. (1998). Hyperbaric oxygen pre-treatment attenuates hepatic reperfusion injury. Liver,
  53. (2008). Hyperbaric oxygen preconditioning induces tolerance against brain ischemia-reperfusion injury by upregulation of antioxidant enzymes in rats. Brain Res.,
  54. (2009). Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by inhibition of apoptosis via mitochondrial pathway in rat brain. Neuroscience,
  55. (2009). Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms.
  56. (2002). Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model. Brain Res.,
  57. (1995). Hyperbaric oxygenation reduces the cytostatic activity and transcription of nitric oxide synthetase gene of mouse peritoneal macrophages.
  58. (1998). Identification of a neurotrophic sequence in erythropoietin.
  59. (2009). IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells,
  60. (2004). Indomethacin prophylaxis for intraventricular hemorrhage in very low birth weight babies.
  61. (2002). Inhibition of nNOS and iNOS following hypoxia-ischaemia improves long-term outcome but does not influence the inflammatory response in the neonatal rat
  62. (2009). Inhibition of the JNK/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury.
  63. (1994). Inhibitor of nitric oxide synthesis reduces hypoxicischemic brain damage in the neonatal rat.
  64. (2009). Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats.
  65. (2008). Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats.
  66. (2008). Iron metabolism and lipid peroxidation products in infants with hypoxic ischemic
  67. (2009). Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia-ischemia.
  68. (2006). Long-term effect of moderate and profound hypothermia on morphology, neurological, cognitive and behavioural functions in a rat model of perinatal asphyxia. Amino Acids,
  69. (2005). Long-term neuroprotection with 2-iminobiotin, an inhibitor of neuronal and inducible nitric oxide synthase, after cerebral hypoxia-ischemia in neonatal rats.
  70. (1998). Low dose flunarizine protects the fetal brain from ischemic injury in sheep.
  71. (2008). Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA-mediated calcium influx, arachidonic acid metabolism, and free radical production.
  72. (2009). Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S100B. Pediatrics,
  73. (2005). Mechanisms of hyperbaric oxygen and neuroprotection in stroke. Pathophysiology,
  74. (1993). Mechanisms of nitric oxide mediated neurotoxicity in primary brain cultures.
  75. (2000). Melatonin and its relation to the immune system and inflammation.
  76. (2008). Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats.
  77. (2007). Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion.
  78. (2010). Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav. Immun.,
  79. (2009). Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus.
  80. (2009). Moderate hypothermia to treat perinatal asphyxial encephalopathy.
  81. (1993). Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen.
  82. (2005). Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke,
  83. (2009). Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury.
  84. (2005). Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Neurotoxicology,
  85. (2009). Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats.
  86. (2008). Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res. Rev.,
  87. (2007). Neurotrophins in the dentate gyrus.
  88. (2008). New concepts in perinatal hypoxia ischemia encephalopathy.
  89. (1999). Nitric oxide synthase inhibition and delayed cerebral injury after severe cerebral ischemia in fetal sheep.
  90. (2003). Non-protein-bound transition metals and hydroxyl radical generation in cerebrospinal fluid of newborn infants with hypoxic ischemic encephalopathy.
  91. (2005). Nonprotein-bound iron in brain interstitium of newborn pigs after hypoxia.
  92. (2007). One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke,
  93. (2001). Oxidant mechanisms in neonatal hypoxia-ischemia.
  94. (2007). Pathological apoptosis in the developing brain. Apoptosis,
  95. (2008). Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia.
  96. (2001). Pharmacotherapeutical reduction of posthypoxic-ischemic brain injury in the newborn.
  97. (2004). Prevention of intraventricular hemorrhage by indomethacin in male preterm infants.
  98. (2008). Pro-inflammatory disequilibrium of the IL-1 beta/IL-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia. Cytokine,
  99. (2005). Prolonged hypothermia protects neonatal rat brain against hypoxic-ischemia by reducing both apoptosis and necrosis. Brain Dev.,
  100. (2006). Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks' gestation at birth. Pediatrics,
  101. (2001). Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev.,
  102. (2000). Protective effect of aminoguanidine on hypoxicischemic brain damage and temporal profile of brain nitric oxide in neonatal rat.
  103. (2009). Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke,
  104. (1983). Reduction of skeletal muscle necrosis using intermittent hyperbaric oxygen in a model compartment syndrome.
  105. (2009). Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes. Brain Res. Rev.,
  106. (2002). Role of caspase-3 activation in cerebral ischemiainduced neurodegeneration in adult and neonatal
  107. (1996). Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics,
  108. (2006). Selective inhibition of nuclear factor-kappaB activation after hypoxia/ischemia in neonatal rats is not neuroprotective.
  109. (2004). Serum insulin-like growth factor 1 and growth hormone levels of hypoxic-ischemic newborns.
  110. (2009). Signaling pathway involved in hypoxia-inducible factor-1alpha regulation in hypoxic-ischemic cortical neurons in vitro.
  111. (2008). Strong neuroprotection by inhibition of NFkappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke,
  112. (2005). The basic physiology and pathophysiology of melatonin. Sleep Med. Rev.,
  113. (2003). The effect of a global birth asphyxia on the ontogeny of BDNF and NGF protein expression in the juvenile brain. Brain Res.
  114. (2007). The effect of infusing hypoxanthine or xanthine on hypoxic-ischemic brain injury in rabbits.
  115. (2009). The effects of indomethacin on caspases, glutathione level and lipid peroxidation in the newborn rats with hypoxic-ischemic cerebral injury. Brain Res.,
  116. (2009). The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice.
  117. (2009). The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury. Brain Res. Rev.,
  118. (1990). The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants.
  119. (2000). The window of opportunity for neuronal rescue with insulin-like growth factor-1 after hypoxia-ischemia in rats is critically modulated by cerebral temperature during recovery.
  120. (2001). Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats.
  121. (2009). Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.
  122. (2008). Therapeutic hypothermia for birth asphyxia in low-resource settings: a pilot randomised controlled trial. Lancet,
  123. (2008). Therapeutic hypothermia in neonates. Review of current clinical data, ILCOR recommendations and suggestions for implementation in neonatal intensive care units. Resuscitation,
  124. (2008). Therapeutic window of hyperbaric oxygen therapy for hypoxicischemic brain damage in newborn rats. Brain Res.,
  125. (2008). Therapeutics for neonatal brain injury.
  126. (2007). Treatment of hypoxic-ischemic encephalopathy in newborns.
  127. (2004). Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke,
  128. (2009). Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche. Brain Res.,
  129. (2008). Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke,
  130. (2006). Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke,